The emergence of the COVID-19 pandemic has starkly illuminated the potential havoc that can be wrought by a single viral pathogen when exploiting comorbidities stemming from metabolic dysfunction. This crisis serves as a poignant reminder of the pressing necessity to address the fundamental issues contributing to metabolic dysfunction, especially among the younger demographic, who would otherwise face heightened vulnerability to both chronic and infectious diseases.

Metabolic diseases, contributing significantly to leading causes of preventable and premature deaths such as ischemic heart disease, stroke, various cancers (breast, prostate, colorectal), obesity, type 2 diabetes, and low bone mineral density, are influenced by a multitude of factors.